Pharma Components ApS Financials, key figures and credit report
Gross profit -35.2 kDKK FY 2025 -110.5% vs 2024
EBIT -35.2 kDKK FY 2025 -110.5% vs 2024
Net debt -82.9 kDKK FY 2025 +79.7% vs 2024
Quick ratio 1.5 FY 2025 -0.2 vs 2024
Income statement (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | -21.91 | 68.54 | 232.22 | 336.41 | -35.18 |
| EBIT | -21.91 | 68.54 | 232.22 | 336.41 | -35.18 |
| Other financial income | 0.32 | 0.52 | 31.55 | 0.62 | 0.57 |
| Other financial expenses | -1.23 | -4.94 | -10.96 | - 153.55 | - 112.29 |
| Pre-tax profit | -22.82 | 64.11 | 252.82 | 183.49 | - 146.90 |
| Income taxes | -7.03 | -56.68 | -41.44 | 31.72 | |
| Net earnings | -22.82 | 57.08 | 196.14 | 142.05 | - 115.17 |
Assets (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Investments total | |||||
| Long term receivables total | |||||
| Finished products/goods | 12.00 | 82.52 | 92.08 | 95.60 | |
| Inventories total | 12.00 | 82.52 | 92.08 | 95.60 | |
| Current trade debtors | 7.72 | 54.93 | 312.12 | ||
| Current amounts owed by group member comp. | 7.91 | ||||
| Current other receivables | 11.33 | 18.37 | 9.39 | 9.54 | 10.11 |
| Current deferred tax assets | 31.72 | ||||
| Short term receivables total | 26.96 | 18.37 | 9.39 | 64.46 | 353.95 |
| Other current investments | 27.39 | 262.13 | 223.49 | 117.29 | |
| Cash and bank deposits | 32.16 | 69.53 | 272.88 | 425.41 | 52.44 |
| Cash and cash equivalents | 32.16 | 96.91 | 535.01 | 648.90 | 169.73 |
| Balance sheet total (assets) | 59.12 | 127.29 | 626.92 | 805.45 | 619.29 |
Equity and liabilities (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Share capital | 40.00 | 40.00 | 40.00 | 40.00 | 40.00 |
| Retained earnings | -24.88 | -47.70 | 9.38 | 205.52 | 347.57 |
| Profit of the financial year | -22.82 | 57.08 | 196.14 | 142.05 | - 115.17 |
| Shareholders equity total | -7.70 | 49.38 | 245.52 | 387.57 | 272.39 |
| Non-current liabilities total | |||||
| Current trade creditors | 0.23 | 61.03 | 5.05 | 33.72 | |
| Current owed to group member | 202.05 | 240.88 | 86.84 | ||
| Short-term deferred tax liabilities | 7.03 | 56.68 | 41.44 | ||
| Other non-interest bearing current liabilities | 66.81 | 70.65 | 61.64 | 130.51 | 226.33 |
| Current liabilities total | 66.81 | 77.91 | 381.40 | 417.88 | 346.89 |
| Balance sheet total (liabilities) | 59.12 | 127.29 | 626.92 | 805.45 | 619.29 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated